Clear Search

Books+ Search Results

Subject with Hierarchy: Is
Is Is Not
Drugs > Generic substitution > Government policy > United States

Advanced Search

Basic Search
Help
Add a row
Reset

Limit results by

Show Online Results Only
Online Results (2)
1.
Biosimilar implementation : a progress report from FDA : hearing before the Subcommittee on Primary Health and Retirement Security of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, first session, on examining biosimilar implementation, focusing on a progress report from FDA, September 17, 2015
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Retirement Security, author
Published
Washington : U.S. Government Publishing Office, 2017.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.114-700
Format
Books
2.
Biosimilar implementation : a progress report from FDA : hearing before the Subcommittee on Primary Health and Retirement Security of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, first session ... September 17, 2015
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Retirement Security, author
Published
Washington : U.S. Government Publishing Office, 2017.
Online
https://purl.fdlp.gov/GPO/gpo86316
Location
Yale Internet Resource >> None
Format
Books / Online
3.
Guidance for industry alternate source of the active pharmaceutical ingredient in pending ANDAs
Published
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2000]
Online
http://purl.access.gpo.gov/GPO/LPS117040
Location
Yale Internet Resource >> None
Format
Books / Online